Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies?
Ewa M Michalak, Jane E Visvader
Molecular Oncology | WILEY | Published : 2016
Awarded by Australian National Health and Medical Research Council (NHMRC)
The breast cancer laboratory is supported by the Australian National Health and Medical Research Council (NHMRC) grants no. 1016701, no. 1024852, no. 1086727; NHMRC IRIISS; the Victorian State Government through VCA funding of the Victorian Breast Cancer Research Consortium and Operational Infrastructure Support; and the Australian Cancer Research Foundation. E.M.M. is supported by a National Breast Cancer Foundation Career Development Fellowship and J.E.V. by a NHMRC Australia Fellowship. We thank K. Hogg for critical reading of the manuscript and P. Maltezos for assistance with preparation of figures.